Palisade Bio’s AI-Driven Approach to IBD Heterogeneity and Efficacy Selected for Presentation at the 3rd Annual Precision Medicine in Inflammatory Bowel Disease Summit

Core Insights - Palisade Bio, Inc. has been selected to present at the 3rd Annual Precision Medicine in Inflammatory Bowel Disease Summit, highlighting its focus on innovative therapeutics for autoimmune and inflammatory diseases [1][2] - The presentation will discuss the use of AI-driven insights to improve patient subtyping and treatment personalization in inflammatory bowel disease (IBD) [2] Company Overview - Palisade Bio is a clinical-stage biopharmaceutical company dedicated to developing novel therapeutics for patients with autoimmune, inflammatory, and fibrotic diseases [3] - The company aims to transform the treatment landscape through a targeted approach with its therapeutics [3]